Navigation Links
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
Date:5/28/2008

ent risk factor for CHD and ischemic stroke. Changes in biomarkers suggested a possible reduction in systemic inflammatory burden. In addition, GSK stated in February 2008 that the results of its randomized Phase 2/3 imaging trial of darapladib in coronary artery disease will be presented and published in the second half of 2008.

SYNCRIA(R): POSSIBLE PHASE 3 DECISION IN 2008

Syncria (albiglutide) is a novel long-acting form of GLP-1 (glucagon-like peptide 1) created by HGS using its proprietary albumin-fusion technology, and licensed to GSK in 2004. Syncria is generated from the genetic fusion of human albumin and GLP-1, a peptide hormone that acts throughout the body to help maintain normal blood-sugar levels and to control appetite. GSK is developing Syncria as a treatment for type 2 diabetes mellitus, and initiated a randomized Phase 2b dose-ranging clinical trial of Syncria in May 2007 in patients with type 2 diabetes. As a comparison, one group of patients is receiving Byetta (exenatide).

HGS is entitled to fees and milestone payments, some of which have already been received, that could amount to as much as $183 million, in addition to single-digit royalties on worldwide sales if Syncria is commercialized. HGS believes it is possible that GSK will reach a decision in 2008 regarding whether to advance Syncria to Phase 3 development.

HGS ANALYST DAY WEBCAST

HGS senior executives will provide an overview of the Company at its Analyst and Investor Meeting today in New York, starting at 12 noon Eastern time. The presentations will be webcast and may be accessed at http://www.hgsi.com. Investors interested in listening to the live webcast should log on before the presentations begin in order to download any software required. The archive of the presentations will be available for several days following the meeting.

ABOUT HUMAN GENOME SCIENCES

The mission of HGS is to app
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
2. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
3. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
6. First Human Implant of New Archus Orthopedics Facet Replacement System
7. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Data Show SuperGens MP-470 is Safe in Humans
10. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... NEW YORK , July 30, 2015 ... releases a new research report with market ... size, share, forecast, porter analysis, recent developments, ... Global Industry Insight: Biosensors Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... AUSTIN, Texas , July 30, 2015 ... solutions company focused on gynecologic disease, announced ... 2015 financial results after the market close ... an investor conference call and webcast at ... August 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... ... Practice, Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to announce ... in a mobile application format available on iPhones, iPads, and Android smartphones ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Radiology Business Management Association’s ... presenting “What’s Next for Health Care: A View From Capitol Hill” on Sunday, Sept. ... Congressional Health Caucus, Rep. Burgess has a special understanding of the real world impact ...
(Date:7/31/2015)... Georgia (PRWEB) , ... July 31, 2015 , ... Super-Sod ... Houzz.com with a Super-Sod Pro Page as the perfect fit for such ... via pictures and articles. The social website is a dynamic site that spreads home ...
(Date:7/31/2015)... ... 31, 2015 , ... Easter Seals Southern Georgia’s Heels & Wheels Duathlon & Triathlon will be ... be 7:30 AM. The duathlon is a 2 mile run, 13 mile bike ride, and ... a 13 mile bike, and a 3 mile run. Heels & Wheels is sponsored ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... applies when purchasing disability insurance, where price is an important factor to clients ... a leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where advisers ...
Breaking Medicine News(10 mins):Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2
... MONDAY, Aug. 16 (HealthDay News) -- A new study finds that ... lower than what their wife or female partner makes, while women ... their husband or male partner. The findings suggest that disparities ... the young couples they studied. "With women, they were less ...
... We all want that summer glow that comes from a day ... implications for our health. Now Dr. Niva Shapira of Tel Aviv ... in the sun safer ― and it,s all in our food. ... Dr. Shapira has shown that a diet rich in antioxidants and ...
... 2010 Young adults who abuse amphetamines may be at ... leading from the heart, UT Southwestern Medical Center researchers have ... of American Heart Journal , researchers examined medical records ... old hospitalized from 1995 to 2007 and found that amphetamine ...
... assesses donor characteristics impacting liver transplantation outcomes, does not bear ... is suggested from large-scale, national data. Rather, hepatitis ... to poor graft survival in transplant patients, according to a ... were to confirm the effect of the Donor Risk Index ...
... implications for developing treatments against cancer and potentially deadly ... the function of proteins that can enhance the progression ... published in the journal Genes and Development . ... professor of cell biology, and Christopher Hellen, DPhil, associate ...
... researchers found that terminology and efforts to frame an ... have no effect on public opinion concerning the ongoing ... Using an experimental approach involving a nationally representative sample, ... not rhetoric, such as the use of ,same-sex couple, ...
Cached Medicine News:Health News:Infidelity Rises When She Makes More Than He Does 2Health News:Infidelity Rises When She Makes More Than He Does 3Health News:SPF on your plate 2Health News:SPF on your plate 3Health News:Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report 2Health News:Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale 2Health News:Researchers find function of proteins that can enhance the progression of viruses and cancer cells 2Health News:Rhetoric, framing efforts have little influence in same-sex marriage debate 2
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician....
... of the authoritative 2005 edition ... Code of Federal Regulations (CFR) ... published in the Federal Register. ... released by the Government Printing ...
... The Quality Module QS I evaluates ... of centrifuged serum samples. The System ... and recognizes if a sample contains ... with the Aliquoting System RSD 800A ...
Medicine Products: